Description
▪ Introduction
Boldenate by Proton Pharma contains Boldenone Undecylenate 250 mg/mL, a long-acting injectable compound originally developed for veterinary applications. In regulated environments, it is studied for its potential role in supporting red blood cell production, nitrogen balance, and metabolic function in investigational research and clinical studies. Its long-acting ester makes it suitable for extended-release protocols requiring less frequent administration.
Boldenate is manufactured to strict pharmaceutical-grade standards, ensuring consistent dosage accuracy, sterility, and formulation integrity. Supplied in a pack of 10 × 1 mL ampoules, this injectable solution is designed exclusively for clinical and analytical use by licensed professionals.
▪ Product Details (Bulleted)
-
Active Ingredient: Boldenone Undecylenate
-
Dosage Strength: 250 mg/mL
-
Form: Injectable solution (intramuscular)
-
Brand: Proton Pharma
-
Package Size: 10 × 1 mL ampoules
-
Intended Use: Regulated medical and analytical research environments only
▪ Pharmacokinetics
Boldenone Undecylenate features a prolonged half-life of approximately 14 days due to its undecylenate ester. This extended release profile supports dosing intervals of 1–2 weeks, making it efficient for long-term study protocols that require steady plasma levels. It has been investigated for its effects on erythropoiesis and nitrogen retention under controlled clinical conditions.
▪ Usage Recommendations
-
Typical Use: Administered only under the supervision of a licensed healthcare provider
-
Route: Intramuscular injection
-
Frequency: Every 1–2 weeks based on investigational protocols
-
Handling: Use aseptic techniques and follow institutional safety protocols
▪ Disclaimer
This product is intended strictly for use in licensed clinical or research environments. It is not approved for general consumer use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical contraindications. All use must comply with local regulations and institutional guidelines.